Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 453

Cited In for PubMed (Select 9520411)

1.

β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease.

Silva Vde O, Lobato RV, Andrade EF, de Macedo CG, Napimoga JT, Napimoga MH, Messora MR, Murata RM, Pereira LJ.

PLoS One. 2015 Aug 20;10(8):e0134742. doi: 10.1371/journal.pone.0134742. eCollection 2015.

2.

Osteoclasts: New Insights.

Xu F, Teitelbaum SL.

Bone Res. 2013 Mar 29;1(1):11-26. doi: 10.4248/BR201301003. eCollection 2013 Mar. Review.

3.

Host response mechanisms in periodontal diseases.

Silva N, Abusleme L, Bravo D, Dutzan N, Garcia-Sesnich J, Vernal R, Hernández M, Gamonal J.

J Appl Oral Sci. 2015 May-Jun;23(3):329-55. doi: 10.1590/1678-775720140259.

4.

The regulation of osteoclast differentiation by Wnt signals.

Kobayashi Y, Uehara S, Koide M, Takahashi N.

Bonekey Rep. 2015 Jul 1;4:713. doi: 10.1038/bonekey.2015.82. eCollection 2015. Review.

PMID:
26157576
5.

Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflammatory bone resorption, and protects against alveolar bone loss in mice.

Tominari T, Matsumoto C, Watanabe K, Hirata M, Grundler FM, Miyaura C, Inada M.

FEBS Open Bio. 2015 Jun 12;5:522-7. doi: 10.1016/j.fob.2015.06.003. eCollection 2015.

6.

Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy.

Petrova NL, Petrov PK, Edmonds ME, Shanahan CM.

J Diabetes Res. 2015;2015:917945. doi: 10.1155/2015/917945. Epub 2015 Jun 2.

7.

Effects of eldecalcitol on cortical bone response to mechanical loading in rats.

Yamasaki Y, Nagira K, Osaki M, Nagashima H, Hagino H.

BMC Musculoskelet Disord. 2015 Jun 30;16:158. doi: 10.1186/s12891-015-0613-3.

8.

TNFα signaling regulates cystic epithelial cell proliferation through Akt/mTOR and ERK/MAPK/Cdk2 mediated Id2 signaling.

Zhou JX, Fan LX, Li X, Calvet JP, Li X.

PLoS One. 2015 Jun 25;10(6):e0131043. doi: 10.1371/journal.pone.0131043. eCollection 2015.

9.

Mechanisms of Bone Resorption in Periodontitis.

Hienz SA, Paliwal S, Ivanovski S.

J Immunol Res. 2015;2015:615486. doi: 10.1155/2015/615486. Epub 2015 May 3. Review.

10.

Osteoprotegerin in breast cancer: beyond bone remodeling.

Weichhaus M, Chung ST, Connelly L.

Mol Cancer. 2015 Jun 10;14:117. doi: 10.1186/s12943-015-0390-5.

11.

Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis.

Törring O.

Ther Adv Musculoskelet Dis. 2015 Jun;7(3):88-102. doi: 10.1177/1759720X15579189. Review.

12.

Proteomic study of different culture medium serum volume fractions on RANKL-dependent RAW264.7 cells differentiating into osteoclasts.

Xiong Q, Zhang L, Xin L, Gao Y, Peng Y, Tang P, Ge W.

Proteome Sci. 2015 May 2;13:16. doi: 10.1186/s12953-015-0073-6. eCollection 2015.

13.

OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism.

Ardeshirpour L, Dumitru C, Dann P, Sterpka J, VanHouten J, Kim W, Kostenuik P, Wysolmerski J.

Endocrinology. 2015 Aug;156(8):2762-73. doi: 10.1210/en.2015-1232. Epub 2015 May 11.

PMID:
25961842
15.

Mammary gland-specific expression of biologically active human osteoprotegerin in transgenic mice.

Sung YY, Lee CS.

Balsaenggwa Saengsig. 2013 Mar;17(1):1-8. doi: 10.12717/DR.2013.17.1.001.

16.

The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.

Kim HR, Kim KW, Kim BM, Cho ML, Lee SH.

PLoS One. 2015 Apr 20;10(4):e0124909. doi: 10.1371/journal.pone.0124909. eCollection 2015.

17.
18.

NF-κB-Mediated Regulation of Osteoclastogenesis.

Boyce BF, Xiu Y, Li J, Xing L, Yao Z.

Endocrinol Metab (Seoul). 2015 Mar 27;30(1):35-44. doi: 10.3803/EnM.2015.30.1.35. Review.

19.

Childhood obesity, bone development, and cardiometabolic risk factors.

Pollock NK.

Mol Cell Endocrinol. 2015 Jul 15;410:52-63. doi: 10.1016/j.mce.2015.03.016. Epub 2015 Mar 27. Review.

PMID:
25817542
20.

CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.

Tsushima H, Okazaki K, Ishihara K, Ushijima T, Iwamoto Y.

Arthritis Res Ther. 2015 Feb 17;17:31. doi: 10.1186/s13075-015-0532-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk